Quantitative 68Ga-PSMA-11 PET and Outcomes in Metastatic Castration-resistant Prostate Cancer following 177Lu-PSMA-617
22.10.2024
0:00
30:54
Dr. Ashwin Singh Parihar speaks with Dr. Phillip Kuo, Dr. Andrew Armstrong, and Dr. Ken Herrmann about how 68Ga-PSMA-11 PET can predict response of metastatic prostate cancer following 177Lu-PSMA-617 therapy. The VISION Trial.
Flere episoder fra "Radiology Podcasts | RSNA"
Gå ikke glip af nogen episoder af “Radiology Podcasts | RSNA” - abonnér på podcasten med gratisapp GetPodcast.